IRS1 and squamous cell carcinoma: Interestingly, Han et al. reported that 43.6% of NSCLC specimens showed loss of IRS-1 expression, and downregulation of IRS-1 is more frequently observed in squamous cell carcinoma than other type lung cancer [40].